Details of the Drug
General Information of Drug (ID: DMG8A74)
| Drug Name |
Naphthalene-2-carboxylic acid hydroxyamide
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-Naphthohydroximic acid; 2-Naphthylhydroxamic acid; N,N-Naphthaloylhydroxylamine; 2-NAPHTHOHYDROXAMIC ACID; 10335-79-2; 2-Naphthoylhydroxamic acid; 2-Naphthalenecarboxamide, N-hydroxy-; N-Hydroxy-2-naphthalenecarboxamide; Naphthalene-2-carboxylic acid hydroxyamide; CHEMBL156672; N-hydroxynaphthalene-2-carboxamide; SCHEMBL6010034; AC1L18K7; DTXSID70145795; KUC110312N; BDBM50015160; AKOS000178377; KSC-264-28-1; LS-95339; 2-Naphthalenecarboxamide, N-hydroxy- (9CI)
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 187.19 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 2.5 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


